gm76Pzw0KT
further articles in following tweet

2017 Biomerieux
https://t.co/hrCU2xVi3U
2016
https://t.co/ZpyQ4WeUWZ
2016
https://t.co/ua10Y0fu0Z
2015 mice influenca
https://t.co/vaJVnItF3B

More from rubic3n

rubic3n
@rubic3n

Fondation Merieux
2017
Pushing the
CEPI Dialogue

Excellent presentation to see, how they, including Bancel, had layed out the narrative.
Quess, what they had specifically included in their list of targeted viruses?

https://t.co/J5FDe6W986

Fondation Merieux 2017
CEPI
Almost basking about their list being more inclusive, more emergent viruses based.
https://t.co/J5FDe6W986

Fondation Merieux 2017
Narrative: "Look, what ZIKA has done to your populace. Nasty ZIKA."

How much of that ZIKA damage was actually related to a virus? Was there a computer guy, who had invested in mosquitos as a vector?

https://t.co/J5FDe6W986

Fondation Merieux 2017
What is the advanges of a programme like CEPI.

And for who?

Let me translate: They want a coordinated vaccine production, with only one strong production pipeline, and solidly regulated pathsways.
Provide the incentives for big pharma.

They've made it.

Vision - look at nasty ZIKA, you surely do not want that
Mission - get the pipeline going of (only) the big ones
Scope - the anti-cancer platforms with their DNA, mRNA basis fit perfectly. They so far do not sell very well, but they could be recycled.

Correct me, if I am wrong.

rubic3n
@rubic3n

@PParzival Es gabe eine parallele Entwicklung mit der Entwicklung der mRNA. Im Packet mit LNP (Lipid Nano Partikeln, den Vehikeln), und Graphene (zur Trennung im Herstellungsprozess, aber auch mögliche andere Effekte wie Tight Junction Öffnung) und der breiten Produktpalette der Hydrogels.

Mit einer nie da gewesenen Hoffnung auf:
- neue industrielle Revolution (meist Graphene basiert, durchsichtig, stretchy, SPIN tech fähig, mit regelbarer Ladung, Magnetizität in ALLEN Lebensbereichen) -damit MEHR PROFIT für die Computerindustrie mit geringeren Entwicklungssprüngen

2011 Ein bedeutendes Jahr mit großem finanziellen Commitment der großen
2012 George Church Emergency Summit on rogue self-replicating Nano Bots (da noch nicht eingetreten, aber den Giftkochern schon bewußt)
2015 Buy-in in alle großen mRNA Impfstoff Platformen.

Auch 2015, PR roll-out Gates Concept Designerin Health (Impfstoffe und Weltkörperkontroll Organisation (natürlich nennen sie es anders, übrigens nicht WHO) Sue Desmond-Hellmann
2016 großer Moderna Niederschlag mit tödlichen Vehikel
Gleichzeitig Push neue LNP Entwicklung

2018 Baric plug in your spike Lego Technik einsatzbereit. Gates Munich Security Conference 'Es wird einen Terroristischen Virenanschlag geben'; Fauci 'There is going to be a surprise outbreak'
2018 Enigma Lieferung nach Wuhan, damit zweite 'No see um' DNA RNA Technologie für Lego

rubic3n
@rubic3n

@Keane1975 Die Forschung mit Virenmanipulation und mRNA Impfstoffen geht dem schon seitlich weit voraus.
Nachfolgend
- zum Bau des Labors in Wuhan durch BioMerieux -> Bancel jetzt Moderna
- Werbebroschüre BioMerieux (CEPI GAVI Einbindung)
- Moderna ominöser geheimer weiterer Impfstoff
1

Bau des Labors in Wuhan BioMerieux Beteiligung
2004

CCP
US
France
all in.
Gates Biontech, Biomerieux Moderna, Gilead Trump
All in.
Who is more?@franciscodeasis https://t.co/ADowRaYHsL
— rubic3n (@rubic3n) February 19, 2021

Bancel BioMerieux

However, through the Bancel (WEF), James Le Duc, Biomerieux gateway France still stayed pretty well in the game - however, sophisticatedly covered. Quite a camouflage masterpiece.

This is where 100Mio EU funding went?https://t.co/hFvdBS62rY https://t.co/jkJgyBdiYk pic.twitter.com/rulfKhKIWw
— rubic3n (@rubic3n) August 29, 2021

Mehr zum Bau des Labors durch BioMerieus in Wuhan (Stephane Bancel ex BioMerieux jetzt

biomerieux has the lab in lyon and they also made the lab in wuhan. https://t.co/dmgTLZ1kEK
— Bianca, fight the abolition of human rights (@Bianca50406170) November 16, 2021

Bancel BioMerieux Wuhan

I\u2019m wondering if/when this will catch on... https://t.co/PoBxz4JyiW pic.twitter.com/1rZFot4uxr
— Jesse \u201cEpstein+WEF+\U0001f1fa\U0001f1f3=Malthusianism\U0001f489\u201d Matchey (@JesseMatchey) January 9, 2022

rubic3n
@rubic3n

Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases
https://t.co/gm76Pzw0KT

In memoriam Nicola Bidoli

VLP applications characteristics challenges

VLP Induction of innate and adaptive immunological responses (A) humoral immunity; (B) cell-mediated immunity) by VLPs

VLPs Advantages and limitations of different expression systems for the development of virus-like particles.

VLP vaccines against different viruses and parasites.

rubic3n
@rubic3n

80% of diseases not treatable with 'conventional medicine'. Protein treatment as an alternative with drawbacks.
An 80% market for mRNA. Yet, the vector is the bottleneck causing the limitation.
Viral V is almost a 'use once only' bcs of antibody formation.
LNP sole way to push.

READ THE INTRODUCTION... https://t.co/1k4qZeutit
— Not Your Mom (@Notyour28981739) December 24, 2021

mRNA Therapy - with a gargantuan market - in dire need for a vector.
Viral vectors as a dead ally until 2015.
mRNA Therapy meets enormous resentments.

Luckily, billions of people have now got first hand experience. Obviously, AZ was not that useful in the general drift.

LNP instead of a vector
PFIZER BioNtech

ALC-0315
ALC-0159, DSPC
"This product is for research use only and not for human use."
https://t.co/tNsG5wxVCT

'EMA Zulassung ohne

https://t.co/rSOxRFTZwH https://t.co/gi40e7mUqI https://t.co/3yAElKnXgs https://t.co/QXYZbFxHRq https://t.co/Nb0q026Zvj
— Lexa W. \U0001f1e9\U0001f1ea (@rebew_lexa) December 22, 2021

Official statement by Echelon
Paraphrased - "we do produce it, but only for use in labs.
Pfizer get theirs from other companies. With them it is safe in humans."

No study data presented
A reference to GMP as 'safe in humans'

ALC-0315
ALC-0159, DSPC

PFIZER LNP

This paper claims "It is just like another fatty compound. You eat salad oil and chips as well"

https://t.co/uncdUpkFnI

No, it is not.

1 There's a chasm between an NLP technology that works well in the research lab and something that works for applications that real people use. This was eye-opening when I started my career, and every time I talk to an NLP engineer at @textio, it continues to strike me even now.

2 Research conditions are theoretical and/or idealized. A huge problem for so-called NLP or AI startups with highly credentialed academic founders is that they bring limited knowledge of what it takes to build real products outside the lab.

3 A product is ultimately a thing that people pay for - not just cool technology or user experience. But I’m not even talking about knowledge gaps in go-to-market work. I'm talking purely technical gaps: how you go from science project to performant + delightful user experience.

4 Most commoditized NLP packages solve well-understood problems in standard ways that sacrifice either precision or performance. In a research lab, this is not usually a hard trade-off; in general, no one is using what you make, so performance is less important than precision.

5 In software, when you’re making something for real people to use, these tradeoffs are a big deal. Especially if you’re asking those people to pay for what you’ve made (can’t get away from that pesky GTM thinking). They expect quality, which includes precision AND performance.

Conviction | Patience
@unseenvalue

H was always unseen in S2NL :)

Those who exited at 1500 needed money. They can always come back near 969. Those who exited at 230 also needed money. They can come back near 95.

Those who sold L @ 660 can always come back at 360. Those who sold S last week can be back @ 301

Sir, Log yahan.. 13 days patience nhi rakh sakte aur aap 2013 ki baat kar rahe ho. Even Aap Ready made portfolio banakar bhi de do to bhi wo 1 month me hi EXIT kar denge \U0001f602

Neuland 2700 se 1500 & Sequent 330 to 230 kya huwa.. 99% retailers/investors twitter par charcha n EXIT\U0001f602
— BhavinKhengarSuratGujarat (@IntradayWithBRK) September 19, 2021